Proposed Agenda & Faculty, 3-4 November 2023
08:00am
Registration Opens
08:50am
Welcome and Introduction, Ryan Fitzpatrick, Joana Torres & Millie Long
Session I: Optimizing Biologic Therapies in IBD
09:00am

Anti-TNF therapy in IBD (including biosimilars)
Joana Torres, Hospital Beatriz Ângelo & Hospital da Luz, Portugal
09:25am

Anti-integrin therapy in IBD
Henit Hanay, Rabin Medical Center, Petah Tikva, Israel
09:50am

IL-23 therapies in IBD
Triana Lobaton, Ghent University Hospital, Ghent, Belgium
10:15am
Panel Discussion
10:45am
Coffee Break
Session II: Focus on small molecules in IBD
11:05am

Conventional immunomodulator therapy in IBD – still a role in the armamentarium?
Naila Arebi, St. Mark’s Hospital, Harrow, Middlesex, UK
11:40am

JAK Inhibitors in IBD: Does selectivity matter?
Séverine Vermeire, Leuven, Belgium
12:05pm

S1P Inhibitors in IBD – how do they work and how to use them?
Britta Siegmund, Universitätsmedizin Berlin, Berlin, Germany
12:30pm
Panel Discussion
13:00pm
Independent Expert Discussion with food
Session III: Women’s health in IBD
14:00pm

Contraceptive and Pre-Conception Counseling in IBD: the role of the Gastroenterologist
Marla C. Dubinsky, Icahn School of Medicine Mount Sinai New York
14:25pm

Pregnancy and IBD
Mette Julsgaard, Aarhus University Hospital, Aarhus, Denmark
14:50pm

Post Delivery: Implications for Mum and Baby
Sophie Restellini, Hôpital de La Tour, Switzerland
15:15pm
Panel Discussion
15:45pm
Coffee Break
Session IV: Medical and surgical management of IBD
Chairs: Millie Long & Joana Torres
16:05pm

Non-invasive monitoring of IBD
Federica Furfaro, Istituto Clinico Humanitas IRCCS
16:30pm

Treat to Target in IBD – too much or too little?
Ana Guttierrez, Hospital General Universitario de Alicante
16:55pm

Surgical Management of the female IBD patient
Susana Ourô, Hospital Beatriz Ângelo & Hospital da Luz, Portugal
17:20pm
Panel discussion & Take-home points from day 1, Millie Long & Joana Torres
17:50pm
Session ends
18:00pm
Independent Expert Discussion with food
19:00pm
Day ends
Session V: Lifespan of IBD
09:00am

Considerations for the Management of Pediatric IBD
Lissy de Ridder, The Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands
09:25am

Sexuality in the IBD patient
Joana Roseira, Centro Hospitalar do Algarve, Portugal
9:50am

Considerations for Management of IBD in Older Individuals
Daniela Pugliese, CEMAD – IBD UNIT Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Rome, Italy
10:15am
Panel Discussion
10:45am
Coffee Break
Session VI: Positioning of Therapies in IBD
11:05am

Disease location and Severity: Considerations for Positioning of Therapies
Charlotte Hedin, Karolinska University Hospital in Stockholm, Sweden
11:35am

Safety Considerations for Positioning of Therapies
Millie Long, University of North Carolina,Chapel Hill, North Carolina, USA
11:55am

Management of Pouchitis in 2023: From Antibiotics to Biologics
Iris Dotan, Rabin Medical Center, Petah Tikva, Israel
12:20pm
Panel Discussion
12:50pm
Independent Expert Discussion with food
Session VII: Career Development for Women in IBD
13:50pm

Successful Mentorship: A Guide for Mentees and Mentors,
Iris Dotan, Rabin Medical Center, Petah Tikva, Israel
14:15pm

A Pathway to Leadership for Women in GI: Lessons Learned
Marla C. Dubinsky, Icahn School of Medicine Mount Sinai New York
14:40 pm

Recognition of a Global Leader in IBD
Séverine Vermeire, Leuven, Belgium